Ashwin C. Parenky

1.5k total citations · 1 hit paper
9 papers, 1.1k citations indexed

About

Ashwin C. Parenky is a scholar working on Immunology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Ashwin C. Parenky has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Pharmaceutical Science. Recurrent topics in Ashwin C. Parenky's work include Protein purification and stability (3 papers), Immunotherapy and Immune Responses (3 papers) and Advanced Drug Delivery Systems (3 papers). Ashwin C. Parenky is often cited by papers focused on Protein purification and stability (3 papers), Immunotherapy and Immune Responses (3 papers) and Advanced Drug Delivery Systems (3 papers). Ashwin C. Parenky collaborates with scholars based in United States, Switzerland and India. Ashwin C. Parenky's co-authors include Ripal Gaudana, Ashim K. Mitra, Hari Krishna Ananthula, Varun Khurana, Ashim K. Mitra, Valerie Quarmby, Susan Kirshner, Lakshmi Amaravadi, Heather Myler and Karoline Bechtold-Peters and has published in prestigious journals such as Vaccine, The AAPS Journal and AAPS PharmSciTech.

In The Last Decade

Ashwin C. Parenky

9 papers receiving 1.1k citations

Hit Papers

Ocular Drug Delivery 2010 2026 2015 2020 2010 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashwin C. Parenky United States 6 560 495 325 315 309 9 1.1k
Hari Krishna Ananthula United States 5 534 1.0× 495 1.0× 313 1.0× 284 0.9× 279 0.9× 5 1.1k
Ripal Gaudana United States 9 869 1.6× 713 1.4× 443 1.4× 469 1.5× 416 1.3× 14 1.6k
Mary Joseph India 11 251 0.4× 236 0.5× 262 0.8× 310 1.0× 229 0.7× 31 942
M. Hornof Austria 11 717 1.3× 293 0.6× 146 0.4× 376 1.2× 172 0.6× 19 1.2k
Sulabh Patel United States 14 360 0.6× 213 0.4× 176 0.5× 263 0.8× 168 0.5× 25 803
Jean‐Sébastien Garrigue France 24 751 1.3× 1.3k 2.6× 589 1.8× 163 0.5× 628 2.0× 68 1.8k
Esther Eljarrat‐Binstock Israel 11 279 0.5× 244 0.5× 220 0.7× 236 0.7× 199 0.6× 14 721
Noriyuki Kunou Japan 16 438 0.8× 189 0.4× 403 1.2× 276 0.9× 291 0.9× 18 1.1k
Peter W. J. Morrison United Kingdom 9 419 0.7× 370 0.7× 136 0.4× 167 0.5× 195 0.6× 9 767
Andrea Luaces-Rodríguez Spain 14 208 0.4× 174 0.4× 289 0.9× 171 0.5× 204 0.7× 16 684

Countries citing papers authored by Ashwin C. Parenky

Since Specialization
Citations

This map shows the geographic impact of Ashwin C. Parenky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin C. Parenky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin C. Parenky more than expected).

Fields of papers citing papers by Ashwin C. Parenky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwin C. Parenky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin C. Parenky. The network helps show where Ashwin C. Parenky may publish in the future.

Co-authorship network of co-authors of Ashwin C. Parenky

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwin C. Parenky. A scholar is included among the top collaborators of Ashwin C. Parenky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwin C. Parenky. Ashwin C. Parenky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Nomani, Alireza, Aishwarya Saraswat, Yu Zhang, et al.. (2025). RNA-lipid nanoparticle therapeutics for women’s health. Frontiers in Nanotechnology. 7. 3 indexed citations
2.
Chablani, Lipika, et al.. (2023). Boosting In-Vivo Anti-Tumor Immunity with an Oral Microparticulate Breast Cancer Vaccine and Low-Dose Cyclophosphamide. Vaccines. 11(3). 543–543. 1 indexed citations
3.
Panicker, Gitika, Ashwin C. Parenky, Mangalathu S. Rajeevan, et al.. (2022). Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route. Pharmaceuticals. 15(9). 1128–1128. 3 indexed citations
4.
Parenky, Ashwin C., et al.. (2021). Container Closure and Delivery Considerations for Intravitreal Drug Administration. AAPS PharmSciTech. 22(3). 100–100. 16 indexed citations
5.
Parenky, Ashwin C., et al.. (2019). Harnessing T-cell activity against prostate cancer: A therapeutic microparticulate oral cancer vaccine. Vaccine. 37(41). 6085–6092. 14 indexed citations
6.
Parenky, Ashwin C., Heather Myler, Lakshmi Amaravadi, et al.. (2014). New FDA Draft Guidance on Immunogenicity. The AAPS Journal. 16(3). 499–503. 40 indexed citations
7.
Gaudana, Ripal, Varun Khurana, Ashwin C. Parenky, & Ashim K. Mitra. (2011). Encapsulation of Protein-Polysaccharide HIP Complex in Polymeric Nanoparticles. Journal of Drug Delivery. 2011. 1–7. 27 indexed citations
8.
Gaudana, Ripal, Ashwin C. Parenky, Ravi Vaishya, Swapan Samanta, & Ashim K. Mitra. (2010). Development and characterization of nanoparticulate formulation of a water soluble prodrug of dexamethasone by HIP complexation. Journal of Microencapsulation. 28(1). 10–20. 22 indexed citations
9.
Gaudana, Ripal, Hari Krishna Ananthula, Ashwin C. Parenky, & Ashim K. Mitra. (2010). Ocular Drug Delivery. The AAPS Journal. 12(3). 348–360. 999 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026